Sector
PharmaceuticalsOpen
₹2,409Prev. Close
₹2,406.95Turnover(Lac.)
₹34.43Day's High
₹2,416.45Day's Low
₹2,33252 Week's High
₹3,37952 Week's Low
₹1,292.85Book Value
₹377.51Face Value
₹10Mkt Cap (₹ Cr.)
2,007.66P/E
70.21EPS
34.23Divi. Yield
0.2525 Jul 2024
12:00 AM
Board Meeting
Agenda : Audited Result
26 Jul 2024
12:00 AM
BookCloser
26 Jul 2024
12:00 AM
AGM
Announcement Date: 26 Jul, 2024
10 May 2024
12:00 AM
Dividend
Dividend Amount: 6
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 8.51 | 8.51 | 8.51 | 8.51 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 304.21 | 283.88 | 259.93 | 229.07 |
Net Worth | 312.72 | 292.39 | 268.44 | 237.58 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 219.35 | 208.47 | 169.42 | 134.78 |
yoy growth (%) | 5.21 | 23.04 | 25.7 | 9.32 |
Raw materials | -61.7 | -53.39 | -22.74 | -23.31 |
As % of sales | 28.12 | 25.61 | 13.42 | 17.29 |
Employee costs | -39.11 | -33.45 | -37.15 | -22.28 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 53.25 | 60.06 | 41.22 | 43.7 |
Depreciation | -9.5 | -9.63 | -9.38 | -5.45 |
Tax paid | -13.73 | -14.88 | -10 | -13.14 |
Working capital | 22.11 | 12.78 | 30.69 | 13.13 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 5.21 | 23.04 | 25.7 | 9.32 |
Op profit growth | -15.86 | 36.55 | 6.29 | 20.73 |
EBIT growth | -12.94 | 38.35 | 0.52 | 26.8 |
Net profit growth | -0.96 | 27.79 | 2.17 | 22.52 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 304.55 | 266.09 | 235.01 | 214.33 | 183.27 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 304.55 | 266.09 | 235.01 | 214.33 | 183.27 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 15.25 | 19.56 | 14.16 | 4.68 | 6.37 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,897 | 163.49 | 4,55,021.88 | 237.82 | 0.71 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,925 | 94.67 | 1,57,256.95 | 430 | 0.51 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,523.75 | 30.97 | 1,22,988.41 | 1,055.94 | 0.85 | 3,752.25 | 346.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,392.5 | 76.4 | 1,14,822.61 | 469 | 0.83 | 2,394 | 201.77 |
Dr Reddys Laboratories Ltd DRREDDY | 6,697.4 | 27.12 | 1,11,742.47 | 1,417.2 | 0.6 | 5,823.9 | 1,458.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Bhupendra V Gandhi
Non Executive Director
Sanjiv D Gandhi
Alternate Director
Nina Gandhi
Independent Director
Sandhya Patel
Independent Director
Ashok Bhadakal
Independent Director
Ameet Desai
Managing Director & CEO
Rajiv D Gandhi
Non Executive Director
Ravin Gandhi
Executive Director
PRIYA RAJIV GANDHI
Independent Director
Anil Jain
Independent Director
Jatin Yagneshbhai Trivedi
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Hester Biosciences Ltd
Summary
Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India. Since its incorporation in Apr 87, the Company has been engaged in the production and distribution of vaccines and health products. Headquartered in Ahmedabad, Gujarat, the Company is currently the second-largest maker of poultry vaccines in India, having acquired strong brand equity over the years. The Company principally engages in two business verticals, namely Poultry Healthcare and Animal Healthcare. Its products are registered with several countries, and internal agencies, and have gained widespread recognition in both India and international markets. It has built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh. The products and services offered include over 51 vaccines and 70+ health products. In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals.The Company markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium.The companys own production of veterinary vaccines
Read More
What is the Hester Biosciences Ltd share price today?
The Hester Biosciences Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹2360.05 today.
What is the Market Cap of Hester Biosciences Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Hester Biosciences Ltd is ₹2007.66 Cr. as of 21 Oct ‘24
What is the PE and PB ratio of Hester Biosciences Ltd?
The PE and PB ratios of Hester Biosciences Ltd is 70.21 and 6.54 as of 21 Oct ‘24
What is the 52 Week High and Low of Hester Biosciences Ltd?
The 52-week high/low is the highest and lowest price at which a Hester Biosciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Hester Biosciences Ltd is ₹1292.85 and ₹3379 as of 21 Oct ‘24
What is the CAGR of Hester Biosciences Ltd?
Hester Biosciences Ltd's CAGR for 5 Years at 6.05%, 3 Years at -1.71%, 1 Year at 42.77%, 6 Month at 44.78%, 3 Month at -8.35% and 1 Month at -3.89%.
What is the shareholding pattern of Hester Biosciences Ltd?
The shareholding pattern of Hester Biosciences Ltd is as follows:
Promoters - 53.73 %
Institutions - 0.63 %
Public - 45.64 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
